Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05550896

Platelet Adhesion in the Pathobiology of Aortic Stenosis

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
65 (estimated)
Sponsor
University of Virginia · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers

Summary

Aortic stenosis (AS) is a serious and common condition that affects 2-3% of the population \>65 years of age in Western countries. It is also responsible for extraordinarily high healthcare expenditures, estimated to be over $6 billion annually,2 in part because the primary treatment for severe AS is aortic valve replacement (AVR) which is resource-intensive. Valve abnormalities are frequently recognized before AS becomes severe, or before there is need for guideline-directed procedural intervention, thereby providing an opportunity for pharmacologic intervention to slow disease progression. Yet, all attempts to prevent AS progression in those with degenerative non-congenital forms of disease have failed. The only non-procedural intervention that benefits patients with moderate or greater AS is the aggressive treatment of hypertension, which reduces net left ventricular (LV) afterload (valvulo-arterial impedance \[Zva\]) and can slow secondary LV remodeling. The overall goal of this proposal is to integrate advanced imaging and vascular biology to study how von Willebrand factor (VWF) and platelet adhesion promote AS progression through many parallel pathways, thereby representing a potential therapeutic target. We are hypothesizing that blood markers of abnormal VWF proteolysis and platelet-derived factors, and abnormal valve shear patterns which can be detected by advanced analysis of spectral Doppler on echocardiography are predictors for progressive AS.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiogaphyAssessment of high velocity low amplitude signals on Doppler echocardiography

Timeline

Start date
2023-01-03
Primary completion
2027-08-30
Completion
2028-06-01
First posted
2022-09-22
Last updated
2026-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05550896. Inclusion in this directory is not an endorsement.